TABLE 3.

Univariate analysis of predictors of HCC recurrence

Predictor	HR (95% Cl)	P
No. lesions
2 (vs 1)	1.4 (0.6–3.0)	0.41
3 (vs 1)	5.5(2.2–13.4)	<0.001
Days from HOC to LT	1.0 (1.0–1.0)	0.49
No. LRT	1.2 (0.9–1.5)	0.13
Cold ischemia time (per 1 h increase from 8 h	0.95 (0.87–1.05)	0.31
Donor age (≥ 60 y vs < 60 y)	0.99 (0.41–2.39)	0.98
Microvascular invasion	13.1 (6.8–25.2)	<0.001
Explant grade (as continuous variable)	1.8 (1.3–2.5)	<0.001
Pathologic stage outside Milan	8.9 (3.9–20.6)	<0.001
Age at HCC diagnosis	1.01 (1.0–1.1)	0.47
Sex (female)	2.3 (1.2–4.3)	0.01
Diagnosis of chronic liver disease
HBV (vs HCV)	1.1 (0.5–2.2)	0.85
Other (vs HCV)	1.9 (0.9–4.1)	0.11
Race (vs white)
African	1.4 (0.4–4.9)	0.56
Asian	0.7 (0.3–1.4)	0.26
Hispanic	0.7 (0.3–1.8)	0.50
Others	0.00	0.99
AFP slope (vs −7.5 to 0)
<−7.5	1.8 (0.7–4.4)	0.21
0–7.5	1.9 (0.9–4.1)	0.08
>7.5	3.9(1.5–10.2)	0.005